Greenphire · 7 hours ago
Travel & Customer Service Coordinator- USA
Maximize your interview chances
Financial ServicesPharmaceutical
Insider Connection @Greenphire
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Manages travel and transportation budget for trial participants
Participates in discussions with vendors and internal team members regarding trial participant requirements
Supports hospital or clinical staff relating to trial participant enrollments and visit schedules
Promptly responds to all inquiries of the trial participants and hospital/clinical staff
Contributes to managing projects to profitable level through efficient work process
Acts as point of contact for patient communication regarding air, hotel and ground accommodations
Maintains accurate data including setting up databases and transferring data between internal operating systems
Aids in producing reports as required
Works with Global Study Manager to outline needs and requests of clients and patients
Contributes to managing projects to profitable level through efficient work process
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s Degree or equivalent work experience
Bilingual required; Spanish preferred
Working knowledge of Microsoft Office
Ability to learn new procedures quickly and efficiently
Highly organized and plan-oriented; adept at prioritization and follow-up
Excels in cross-departmental communication
Confidence and follow through in decision-making
Preferred
2-5 years of experience in the travel industry and/or pharma industry preferred
Company
Greenphire
Greenphire offers a technology-based clinical payment and travel solution for global pharmaceutical sponsors, CROs and research sites.
Funding
Current Stage
Growth StageTotal Funding
$5.81MKey Investors
FirstMark
2021-05-26Acquired· by Thoma Bravo
2021-03-24Private Equity· Undisclosed
2012-10-09Series B· $4.31M
Recent News
Business Wire
2024-11-12
2024-04-13
2024-04-13
Company data provided by crunchbase